Medically reviewed by Paul Gonzales on February 16, 2024.
Microdosing hormone replacement therapy (HRT) involves taking lower doses of medications to produce slower, more subtle changes. Estrogen (used synonymously with “estradiol,” which is one of three forms of estrogen found in the human body) is a feminizing hormone that many trans women, transfeminine, non-binary, and gender expansive people take to reduce gender dysphoria or discomfort. Estradiol is usually accompanied by anti-androgens (often referred to as hormone blockers or testosterone blockers), but a regimen and dose should be guided by your specific transitioning goals. Microdosing can involve taking either or both of these medications at low doses.
While microdosing usually refers to testosterone and masculine folks, the Gender Confirmation Center works with feminine-spectrum non-binary patients who seek feminizing HRT. Learn more about how to access estrogen here.
Please note that this page is for informational purposes only and should not be taken as medical advice. It is very important to see an experienced physician who specializes in HRT before taking hormones. The Gender Confirmation Center performs gender affirming surgery and does not prescribe hormones to patients. Starting hormones or adjusting your hormone dose or regimen without a discussion with a hormone specialist has the potential to be dangerous or life threatening. You should seek out a medical provider experienced in hormone treatment if you are considering going on hormones or adjusting your dosage.
Microdosing estradiol and/or anti-androgens can be an effective way to achieve more subtle feminization for feminine-spectrum non-binary people, or for any trans person with similar hormone therapy goals. It is always a best practice to choose the correct hormone dose for you with a doctor.
Similar to testosterone, estradiol and/or anti-androgens impact secondary sex characteristics, which are the changes to the body that happen during puberty in adolescence. UCSF’s guide to feminizing hormone therapy has an in-depth list of the changes that one can expect during feminizing HRT and information relating to the health concerns of estradiol and hormone blockers. Specifically, microdosing HRT is often sought out as a treatment option for the following reasons:
It is important to point out that the use of anti-androgens can be an important part of hormonal feminization for feminine-spectrum trans people. Testosterone blockers are used to lower testosterone levels, enhancing the impact that estrogen can have on the body. Blockers are sometimes used just when someone is starting estrogen, and in other cases are used throughout the entirety of someone’s HRT journey.
For some non-binary people, the use of a testosterone blocker alone can achieve the right amount of feminization. For others, the use of estrogen along with a testosterone blocker is essential. Again, it is recommended to discuss your HRT goals with a doctor to help decide which method is best for you.
Below are some dosing recommendations for the different forms of estrogen used in HRT and two common anti-androgens. Recommendations are taken from UCSF Transgender Care:
Oral Estradiol: A “typical” dose of oral estradiol is in the 2-8 mg range per day. A microdose would be around 1mg daily. Oral estradiol is usually taken sublingually.
Transdermal Patch: Estradiol patches come in different concentration levels, and there are different recommendations for how often a patch can be changed based on the brand. A “normal” patch dose is 100 to 400 mcg per day, and a low dose estrogen patch would be around 50 mcg per day.
Estradiol Valerate: Usually injected intramuscularly, a “normal” dose of estradiol valerate would be between 20 and 40 mg every two weeks. A microdose would be injecting less than 20mg every two weeks. For weekly injections, doses can be divided in half.
Estradiol Cypionate: Also injected intramuscularly, a “typical” dose of estradiol cypionate is between 2 and 5 mg every two weeks. A low dose would be injecting less than 2 mg every two weeks. Similarly to estradiol valerate, doses can be divided in half for weekly injections.
Spironolactone: Commonly referred to as “Spiro,” this testosterone blocker is the most commonly used anti-androgen in the United States. A “normal” dose of Spiro usually falls in the 50 to 200 mg twice per day range. A microdose would be around 25-50mg per day. Spiro is taken orally and is recommended to be taken at mealtimes.
Finasteride: A maximum dose of Finasteride is around 5mg per day, and a low dose is around 1 mg per day.
At the Gender Confirmation Center we strive to make gender-affirming surgeries accessible to patients who have traditionally been marginalized within transgender healthcare: non-binary patients, patients with high BMIs, patients with disabilities and senior patients. We strive to make the highest quality gender-affirming surgical care available and affordable to patients who do not conform with the gender binary. Below are our guidelines and recommendations around surgical eligibility and HRT usage:
If you have questions about how microdosing might affect your surgical outcomes, you can schedule a free, virtual consultation with one of our surgeons today.
In the video below, Dr. Facque (he/him) explains how HRT can effect your breast augmentation results:
Below are some stories that highlight the process of medically transitioning as a non-binary person. People discuss taking low doses of estrogen, talking with doctors about non-binary identity, and what others can expect when starting their own transitioning journey.
All virtual and in-person consultations with our board-certified surgeons are free. Once you fill out this form, our patient care team will reach out and guide you through every step to get to surgery.